SIREN : 403834278
ARCHIMED'CONCEPT is a French company founded 30 years ago, specialized in the sector Ingénierie, études techniques. Based in PARIS (75019), this company of category PME shows in 2021 a revenue of 147 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | 147 057 € | 88 754 € | 54 770 € | 18 492 € | 36 462 € | 68 859 € |
| Net income | 48 357 € | 39 206 € | -3 790 € | -32 478 € | -20 801 € | 7 074 € |
| EBITDA | 49 783 € | 40 028 € | -3 468 € | -31 107 € | -20 707 € | 7 300 € |
| Net margin | 32.9% | 44.2% | -6.9% | -175.6% | -57.0% | 10.3% |
In 2021, ARCHIMED'CONCEPT achieves revenue of 147 k€. Over the period 2016-2021, the company shows strong growth with a CAGR (compound annual growth rate) of +16.4%. Vs 2020, growth of +66% (89 k€ -> 147 k€). After deducting consumption (0 €), gross margin stands at 147 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 50 k€, representing 33.9% of revenue. Warning negative scissor effect: despite revenue change (+66%), EBITDA varies by +24%, reducing margin by 11.2 pts. This reflects costs rising faster than revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 48 k€, i.e. 32.9% of revenue. This profit can be retained or distributed to shareholders.
147 057 €
147 057 €
49 783 €
48 357 €
48 357 €
30.3%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 89%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 30.3% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
0.218%
89.309%
30.279%
0.005
69.9%
In 2021, the debt ratio of ARCHIMED'CONCEPT (0.22) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2021, the financial autonomy of ARCHIMED'CONCEPT (89.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2021, the repayment capacity of ARCHIMED'CONCEPT (0.01) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 831.13. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
831.127
0.0
In 2021, the liquidity ratio of ARCHIMED'CONCEPT (831.13) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2021, the interest coverage of ARCHIMED'CONCEPT (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 37 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 7 days. The company must finance 30 days of gap between collections and payments. Overall, WCR represents 17 days of revenue, i.e. 7 k€ to permanently finance.
6 897 €
37 j
7 j
0 j
17 j
Based on 52 transactions of similar company sales
in 2021,
the value of ARCHIMED'CONCEPT is estimated at
39 437 €
(range 25 935€ - 77 587€).
With an EBITDA of 49 783€, the sector multiple of 0.5x is applied.
The price/revenue ratio is 0.44x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 52 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare ARCHIMED'CONCEPT with other companies in the same sector:
Voir toutes les statistiques du secteur Ingénierie, études techniques
The revenue of ARCHIMED'CONCEPT in 2021 is 147 k€.
Yes, ARCHIMED'CONCEPT generated a net profit of 48 k€ in 2021.
The headquarters of ARCHIMED'CONCEPT is located in PARIS (75019), in the department Paris.
The tax return of ARCHIMED'CONCEPT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
ARCHIMED'CONCEPT operates in the sector Ingénierie, études techniques (NAF code 71.12B). See the 'Sector positioning' section above to compare the company with its competitors.